Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy

European Journal of Radiology

Volumn 81, Issue 10, 2012, Pages 2627-2631

  Takeda, Kazuna ^a   Kanao, Shotaro ^a   Okada, Tomohisa ^a   Kataoka, Masako ^a   Ueno, Takayuki ^a   Toi, Masakazu ^a   Ishiguro, Hiroshi ^a   Mikami, Yoshiki ^a   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Breast cancer; Computer aided measurement; Inter observer agreement; MRI; Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; GADODIAMIDE; GADOTERIDOL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; LONGEST DIAMETER; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; TOTAL ENHANCED VOLUME; TREATMENT RESPONSE; TUMOR VOLUME; VOLUMETRY; WASHOUT VOLUME;

ADULT; AGED; ALGORITHMS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOADJUVANT THERAPY; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84865222484     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.12.013     Document Type: Article

References (20)

1. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault Monitoring therapeutic efficacy in breast carcinomas Eur Radiol 16 11 2006 2549 2558
2. J.A. van der Hage, C.J. van de Velde, J.P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 22 2001 4224 4237
3. R. Yerushalmi, R. Woods, P.M. Ravdin, M.M. Hayes, and K.A. Gelmon Ki67 in breast cancer: prognostic and predictive potential Lancet Oncol 11 2 2010 174 183
4. N. Wolmark, J. Wang, E. Mamounas, J. Bryant, and B. Fisher Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr 30 2001 96 102
5. C. Balu-Maestro, C. Chapellier, A. Bleuse, I. Chanalet, C. Chauvel, and R. Largillier Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI Breast Cancer Res Treat 72 2 2002 145 152
6. K. Takeda, S. Kanao, and T. Okada MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy Eur J Radiol 2011
7. E. Rosen, K. Blackwell, and J. Baker Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy AJR Am J Roentgenol 181 5 2003 1275 1282
8. C. Kuhl, P. Mielcareck, and S. Klaschik Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211 1 1999 101 110
9. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2 2009 228 247
10. K. James, E. Eisenhauer, and M. Christian Measuring response in solid tumors: unidimensional versus bidimensional measurement J Natl Cancer Inst 91 6 1999 523 528
11. S.C. Partridge, J.E. Gibbs, and Y. Lu MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival AJR Am J Roentgenol 184 6 2005 1774 1781
12. S.A. Sohaib, B. Turner, J.A. Hanson, M. Farquharson, R.T. Oliver, and R.H. Reznek CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size Br J Radiol 73 875 2000 1178 1184
13. L. Martincich, F. Montemurro, and G. De Rosa Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging Breast Cancer Res Treat 83 1 2004 67 76
14. P.L. Kubben, A.A. Postma, A.G. Kessels, J.J. van Overbeeke, and H. van Santbrink Intraobserver and interobserver agreement in volumetric assessment of glioblastoma multiforme resection Neurosurgery 67 5 2010 1329 1334
15. S.C. Partridge, E.J. Heumann, and N.M. Hylton Semi-automated analysis for MRI of breast tumors Stud Health Technol Inform 62 1999 259 260
16. K. Akazawa, Y. Tamaki, and T. Taguchi Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy Breast J 14 6 2008 523 531
17. L.I. Lin A concordance correlation coefficient to evaluate reproducibility Biometrics 45 1 1989 255 268
18. M.J. Ratain, and S.G. Eckhardt Phase II studies of modern drugs directed against new targets: if you are fazed, too, then resist RECIST J Clin Oncol 22 22 2004 4442 4445
19. K. Marten, F. Auer, S. Schmidt, G. Kohl, E.J. Rummeny, and C. Engelke Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria Eur Radiol 16 4 2006 781 790
20. W.B. Demartini, C.D. Lehman, S. Peacock, and M.T. Russell Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy Acad Radiol 12 7 2005 806 814